Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?

Summary

Article headline poses a question about whether cancer therapeutics could represent a strategic turnaround for Moderna as it transitions beyond COVID-related products. No specific clinical data, regulatory decisions, or material announcements are provided in the available text.